Parkinson's Disease: Focus on Hallucinations
Patients often hide their hallucinations, which are associated with poor long-term outcomes and a reduced quality of life.
Source: medscape.com
Stay updated with breaking news from Dopamine Agonist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patients often hide their hallucinations, which are associated with poor long-term outcomes and a reduced quality of life.
An experimental drug that combines low-dose extended-release pramipexole and rasagiline showed strong efficacy in early-stage Parkinson's disease — with less sleepiness — in a new phase 3 trial.